KANSAS CITY, Kan. and NEW YORK, Nov. 12, 2012 /PRNewswire/ -- Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today announced that it will participate in Leerink Swann's November Management Access Days, taking place November 19 - 20, 2012, at Leerink Swann's headquarters in Boston, Massachusetts. 

On November 19, 2012, Steven St. Peter, M.D., President and Chief Executive Officer of Aratana, will host one-on-one meetings with investors.  He will be joined by Louise Mawhinney, CPA, Chief Financial Officer, and Linda Rhodes, V.M.D., Ph.D., Chief Scientific Officer of Aratana Therapeutics. 

About Aratana Therapeutics

Aratana Therapeutics is a biopharmaceutical company positioned to deliver high quality new medicines that address significant therapeutic needs for cats and dogs (companion animals).  Aratana licenses and develops proprietary, patent-protected compounds acquired from human pharmaceutical and biotechnology companies and then develops strategies to maximize the value of the programs for the animal health market.  For more information, please visit www.aratanatherapeutics.com.

For Media & Investors:
Jason Rando / Joshua Drumm, Ph.D.
Tiberend Strategic Advisors, Inc.
(212) 827-0020
jrando@tiberend.com
jdrumm@tiberend.com

SOURCE Aratana Therapeutics